NCT05940272View on ClinicalTrials.gov

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

July 3, 2028

Study Completion Date

July 3, 2028

Conditions
Lymphoma, B-CellLymphomaLarge-cell LymphomaLarge B-cell LymphomaDLBCL - Diffuse Large B Cell LymphomaMediastinal B-Cell Diffuse Large Cell Lymphoma
Interventions
BEHAVIORAL

Hematolo-GIST Training

Hematologist will participate in a group Hematolo-GIST training provided remotely via the study team.

BEHAVIORAL

Participants Appointment

Participants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms.

Trial Locations (2)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All protocol activities), New York

NOT_YET_RECRUITING

NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER